On a collision course: SARS-CoV-2 variants and CAR T cells
Blood Adv
.
2023 Jun 13;7(11):2643-2644.
doi: 10.1182/bloodadvances.2023010371.
Author
Jeffery J Auletta
1
2
Affiliations
1
Center for International Blood and Marrow Transplant Research, National Marrow Donor Program, Minneapolis, MN.
2
Hematology/Oncology/Blood & Marrow Transplantation and Infectious Diseases, Nationwide Children's Hospital, Columbus, OH.
PMID:
37310762
PMCID:
PMC10262728
DOI:
10.1182/bloodadvances.2023010371
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antibodies, Monoclonal
COVID-19 Vaccines
COVID-19*
Humans
Immunotherapy, Adoptive
SARS-CoV-2*
T-Lymphocytes
Vaccination
Substances
Antibodies, Monoclonal
COVID-19 Vaccines
Supplementary concepts
SARS-CoV-2 variants